NIH Funding · FY2024
Total Funding
$631.6K
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#25,041
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $631.6K across 3 grants · National rank #25041.
Top grants by award amount
Irfan Ahmed Asangani's NIH grant portfolio, ranked by award amount.
- 5R01CA249210-05R01Role of MED1 in the AR-dependent transcription in advanced prostate cancer$353.1Kaward amount
- 5R21CA274009-02R21Discovery and characterization of exceptionally specific surface oncoprotein LIPI in Ewing Sarcoma$216.5Kaward amount
- 3R01CA249210-05S1R01Role of MED1 in the AR-dependent transcription in advanced prostate cancer$62Kaward amount
Affiliation
Institutions that have administered grants for Irfan Ahmed Asangani.
Affiliated with University of Pennsylvania (PA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardUniversity of Pennsylvania
- 2024$500K Cumulative Funding
Related investigators
Other NIH-funded PIs frequently associated with Irfan Ahmed Asangani.
David A Wolk
4 grants
$31.2M
total funding
Mitchell D. Schnall
4 grants
$24.7M
total funding
Alvin C Powers
9 grants
$19M
total funding
Ali Naji
7 grants
$17.8M
total funding
Klaus H Kaestner
8 grants
$16.2M
total funding
Sara Bonamo Demauro
7 grants
$12.4M
total funding
Mark A. Atkinson
7 grants
$11.1M
total funding
Scott Hensley
4 grants
$10.4M
total funding
Garret A Fitzgerald
1 grant
$10.2M
total funding
Jiang Bian
13 grants
$9.9M
total funding
Explore further
Find collaborators for Irfan Ahmed Asangani
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at University of Pennsylvania
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →